Literature DB >> 6222160

The antimitotic effect of bromocriptine on human fibroblasts.

M Pawlikowski, L Jakubowski, B Kałuzewski.   

Abstract

The effect of bromocriptine on tritiated thymidine incorporation into nuclei of human fibroblasts has been investigated. A dose--dependent decrease of the labelling index has been found. This observation suggests that the antimitotic action of bromocriptine is a more general phenomenon not restricted to the adenohypophysial cells.

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6222160     DOI： 10.1007/bf01243377

Source DB:  PubMed          Journal:  J Neural Transm            Impact factor:   3.575


  13 in total

1.  Effects of oestrogen and bromocryptine on in vivo secretion and mitosis in prolactin cells.

Authors:  H M Lloyd; J D Meares; J Jacobi
Journal:  Nature       Date:  1975-06-05       Impact factor: 49.962

2.  Role of calcium in the control of growth and cell division.

Authors:  A D Perris; J F Whitfield; P K Tölg
Journal:  Nature       Date:  1968-08-03       Impact factor: 49.962

3.  Calcium rather than cyclic AMP as the physiological intracellular regulator of prolactin release.

Authors:  M O Thorner; J T Hackett; F Murad; R M MacLeod
Journal:  Neuroendocrinology       Date:  1980-12       Impact factor: 4.914

4.  Calmodulin stimulates DNA synthesis by rat liver cells.

Authors:  A L Boynton; J F Whitfield; J P MacManus
Journal:  Biochem Biophys Res Commun       Date:  1980-07-31       Impact factor: 3.575

5.  Effects of fibroblast growth factor and bromocriptine on the mitotic activity of the anterior pituitary gland in organ culture.

Authors:  M Pawlikowski; H Stepień
Journal:  Cell Tissue Res       Date:  1979-10-02       Impact factor: 5.249

6.  Effects of pimozide and bromocriptine on anterior pituitary cell proliferation.

Authors:  H Stepień; A Wolaniuk; M Pawlikowski
Journal:  J Neural Transm       Date:  1978       Impact factor: 3.575

7.  Reduction of pituitary-tumour size in patients with prolactinomas and acromegaly treated with bromocriptine with or without radiotherapy.

Authors:  J A Wass; P J Moult; M O Thorner; J E Dacie; M Charlesworth; A E Jones; G M Besser
Journal:  Lancet       Date:  1979-07-14       Impact factor: 79.321

8.  Release of growth hormone from purified somatotrophs: use of high K+ and the ionophore A23187 to elucidate interrelations among Ca++, adenosine 3',5'-monophosphate, and somatostatin.

Authors:  J Kraicer; J W Spence
Journal:  Endocrinology       Date:  1981-02       Impact factor: 4.736

9.  Effects of bromocriptine on pituitary tumour size.

Authors:  A M McGregor; M F Scanlon; R Hall; K Hall
Journal:  Br Med J       Date:  1979-09-22

10.  Rapid regression of pituitary prolactinomas during bromocriptine treatment.

Authors:  M O Thorner; W H Martin; A D Rogol; J L Morris; R L Perryman; B P Conway; S S Howards; M G Wolfman; R M MacLeod
Journal:  J Clin Endocrinol Metab       Date:  1980-09       Impact factor: 5.958
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.